Meta-Analysis: Effects of probiotic supplementation on lipid profiles in normal to mildly hypercholesterolemic individuals

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Shimizu, Mikiko ^a   Hashiguchi, Masayuki ^a   Shiga, Tsuyoshi ^b   Tamura, Hiro Omi ^a   Mochizuki, Mayumi ^a  

^a KEIO UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE OLIGOSACCHARIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROBIOTIC AGENT; YOGHURT;

ADULT; AGE; AGED; ARTICLE; BIFIDOBACTERIUM LONGUM; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DAIRY PRODUCT; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; ENTEROCOCCUS FAECIUM; FEMALE; FERMENTED PRODUCT; HUMAN; HYPERCHOLESTEROLEMIA; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS FERMENTUM; LACTOBACILLUS REUTERI; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL (TOPIC); STREPTOCOCCUS THERMOPHILUS; THERAPY EFFECT; TREATMENT DURATION; BLOOD; DIETARY SUPPLEMENT; MEDLINE;

CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; PROBIOTICS; PUBMED; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84949519623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0139795     Document Type: Article

References (37)

1. World Health Organization (WHO). The World Health Report: 2003; Shaping the Future [WHO website]. Geneva, Switzerland: WHO; 2003. Available at: http://www.who.int/whr/2003/en/whr03-en.pdf. Accessed September 24, 2009.
2. Law MR, Wald NJ, Rudnicka AR. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-Analysis. BMJ. 2003; 326: 1423-9.
3. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004; 110: 227-39.
4. Gould AL, Davies GM, Alemao E, Yin DD, Cook JR. Cholesterol reduction yields clinical benefits: metaanalysis including recent trials. Clin Ther. 2007; 29: 778-94.
5. WHO/FAO scientific document. http://who.int/foodsafety/fs-management/en/probiotic-guidelines.pdf.
6. Gilliland SE, Nelson CR, Maxwell C. Assimilation of cholesterol by Lactobacillus acidophilus. Appl Environ Microbiol. 1985; 49: 377-81.
7. Liong MT, Shah NP. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J Dairy Sci. 2005; 88: 55-66.
8. Lee DK, Jang S, Baek EH, Kim MJ, Lee KS, Shin HS, et al. Lactic acid bacteria affect serum cholesterol levels, harmful fecal enzyme activity, and fecal water content. Lipids Health Dis. 2009; 11: 8-21.
9. Chiu CH, Lu TY, Tseng YY, Pan TM. The effects of Lactobacillus-fermented milk on lipid metabolism in hamsters fed on high-cholesterol diet. Appl Microbiol Biotechnol. 2006; 71: 238-45.
10. Park YH, Kim JG, Shin YW, Kim HS, Kim YJ, Chun T, et al. Effects of Lactobacillus acidophilus 43121 and a mixture of Lactobacillus casei and Bifidobacterium longum on the serum cholesterol level and fecal sterol excretion in hypercholesterolemia-induced pigs. Biosci Biotechnol Biochem. 2008; 72: 595-600.
11. Bukowska H, Pieczul-Mróz J, Jastrzebska M, Chelstowski K, Naruszewicz M. Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis. 1998; 137: 437-8.
12. Naruszewicz M, Johansson ML, Zapolska-Downar D, Bukowska H. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factors in smokers. Am J Clin Nutr. 2002; 76: 1249-55.
13. Anderson JW, Gilliland SE. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on serum cholesterol in hypercholesterolemic humans. J Am Coll Nutr. 1999; 18: 43-50.
14. Kiessling G, Schneider J, Jahreis G. Long-Term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur J Clin Nutr. 2002; 56: 843-9.
15. Ataie-Jafari A, Larijani B, Alavi Majd H, Tahbaz F. Cholesterol-lowering effect of probiotic yogurt in comparison with ordinary yogurt in mildly to moderately hypercholesterolemic subjects. Ann Nutr Metab. 2009; 54: 22-7. doi: 10.1159/000203284
16. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, et al. Effects of milk products fermented by Bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. J Dairy Sci. 2003; 86: 2452-61.
17. Agerholm-Larsen L, Bell ML, Grunwald GK, Astrup A. The effect of a probiotic milk product on plasma cholesterol: A meta-Analysis of short-Term intervention studies. Eur J Clin Nutr. 2000; 54: 856-60.
18. Guo Z, Liu XM, Zhang QX, Shen Z, Tian FW, Zhang H, et al. Influence of consumption of probiotics on the plasma lipid profile: A meta-Analysis of randomised controlled trials. Nutr Metab Cardiovasc Dis. 2011; 21: 844-50. doi: 10.1016/j.numecd.2011.04.008
19. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17: 1-12.
20. Agerbaek M, Gerdes LU, Richelsen B. Hypocholesterolaemic effect of a new fermented milk product in healthy middle-Aged men. Eur J Clin Nutr. 1995; 49: 346-52.
21. Agerholm-Larsen L, Raben A, Haulrik N, Hansen AS, Manders M, Astrup A. Effect of 8 week intake of probiotic milk products on risk factors for cardiovascular diseases. Eur J Clin Nutr. 2000; 54: 288-97.
22. Bertolami MC, Faludi AA, Batlouni M. Evaluation of the effects of a new fermented milk product (Gaio) on primary hypercholesterolemia. Eur J Clin Nutr. 1999; 53: 97-101.
23. Greany KA, Bonorden MJ, Hamilton-Reeves JM, McMullen MH, Wangen KE, Phipps WR, et al. Probiotic capsules do not lower plasma lipids in young women and men. Eur J Clin Nutr. 2008; 62: 232-7.
24. Hata Y, Yamamoto M, Ohni M, Nakajima K, Nakamura Y, Takano T. A placebo-controlled study of the effect of sour milk on blood pressure in hypertensive subjects. Am J Clin Nutr. 1996; 64: 767-71.
25. Simons LA, Amansec SG, Conway P. Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutr Metab Cardiovasc Dis. 2006; 16: 531-5.
26. St-Onge MP, Farnworth ER, Savard T, Chabot D, Mafu A, Jones PJ. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: A randomized controlled trial. BMC Complement Altern Med. 2002; 2: 1-7.
27. Sadrzadeh-Yeganeh H, Elmadfa I, Djazayery A, Jalali M, Heshmat R, Chamary M. The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr. 2010; 103: 1778-83. doi: 10.1017/S0007114509993801
28. Jones ML, Martoni CJ, Prakash S. Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: A randomized controlled trial. Eur J Clin Nutr. 2012; 66: 1234-41. doi: 10. 1038/ejcn.2012.126
29. De Caterina R, Scarano M, Marfisi R, Lucisano G, Palma F, Tatasciore A, et al. Cholesterol-lowering interventions and stroke: insights from a meta-Analysis of randomized controlled trials. J Am Coll Cardiol. 2010; 55: 198-211.
30. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation; 2004; 110: 227-39.
31. Delahoy PJ, Magliano DJ, Webb K, Grobler M, Liew D. The relationship between reduction in low-density lipoprotein cholesterol by statins and reduction in risk of cardiovascular outcomes: An updated meta-Analysis. Clin Ther. 2009; 31: 236-44. doi: 10.1016/j.clinthera.2009.02.017
32. Teramoto T, Sasaki J, Ishibashi S, Birou S, Daida H, Dohi S, et al. Japan Atherosclerosis Society. Executive summary of the Japan Atherosclerosis Society (JAS) guidelines for the diagnosis and prevention of atherosclerotic cardiovascular diseases in Japan-2012 version. J Atheroscler Thromb. 2013; 20: 517-23.
33. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014; 63 (25 Pt B): 2889-934. doi: 10.1016/j.jacc.2013.11.002
34. Lye HS, Rahmat-Ali GR, Liong MT. Mechanisms of cholesterol removal by lactobacilli under conditions that mimic the human gastrointestinal tract. Int Dairy J. 2010; 20: 169-75.
35. Liong MT, Shah NP. Acid and bile tolerance and cholesterol removal ability of lactobacilli strains. J Dairy Sci. 2005; 88: 55-66.
36. Klaver FA, van der Meer R. The assumed assimilation of cholesterol by lactobacilli and Bifidobacterium bifidum is due to their bile salt-deconjugating activity. Appl Environ Microbiol. 1993; 59: 1120-4.
37. Huang Y, Zheng Y. The probiotic Lactobacillus acidophilus reduces cholesterol absorption through the down-regulation of Niemann-Pick C1-like 1 in Caco-2 cells. Br J Nutr. 2010; 103: 473-8. doi: 10.1017/S0007114509991991